Emerging technologies & innovation systems

A disruptive or path-breaking innovation can deliver remarkable advances in healthcare, agriculture, energy, transport and financial services but innovators in these areas are also faced with great uncertainty around the nature of future business models and value chains. Innogen offers new insights and methodological approaches for foresighting future business models and value chains in the context of an innovation ecosystem that can either support or constrain the eventual market availability of the technology. Innogen’s expertise lies in understanding, assessing and supporting this innovation-led growth.

Projects

Meet Innogen Associates: Prof. Iain Gillespie

10 June 2021

We speak with Innogen associate Prof. Iain Gillespie about his recent appointment as Principal and Vice-Chancellor at the University of Dundee. He tells us about some of challenges facing research in the higher education sector and his plans to deliver impactful innovation that changes things for the better.

Reasons to be cheerful, one, two, three.

8 November 2021

Professor Chris Warkup is optimistic about the UK Government's Innovation policy, read his blog post to find out why.

Sustainable aquaculture: Enabling innovation and implementation

4 August 2022

On the 20th of June representatives from the aquaculture sector, academia, environmental and governmental organisations took part in a virtual round table discussion co-hosted by SAIC and Innogen on how best to implement innovations that will improve the sustainability of aquaculture.

Chris Warkup appointed Visiting Professor at Innogen

1 August 2019

Chris Warkup, one of the UK’s leading knowledge exchange practitioners, will be joining the Innogen Institute at The Open University until 2022.

Supporting Africa’s innovation strategy

12 December 2019

In November, Geoff Banda, Innogen Deputy Director, attended the launch of The Health Research and Innovation Strategy for Africa 2018-2030, developed by the African Union Development Agency (AUDA)-NEPAD, and spoke at the 2nd Vaccine Manufacturing Forum.